
Lilly posts 3Q loss of $57M, cuts full-year profit guidance
Excluding nonrecurring items, the Indianapolis-based drugmaker posted adjusted earnings of 10 cents a share, beating Zacks consensus estimate of a loss of 11 cents a share.
Excluding nonrecurring items, the Indianapolis-based drugmaker posted adjusted earnings of 10 cents a share, beating Zacks consensus estimate of a loss of 11 cents a share.
IU’s newest plans are intended to bolster enrollment and establish Indiana University Indianapolis as one of the country’s premier urban research universities.
Syra Health Corp., a Carmel-based health care services company, raised $5.3 million after expenses in its initial public offering. But it faces a slew of challenges, from winning new customers to launching products and services quickly to stem losses.
Eli Lilly and Co. is paying Indianapolis-based startup Point Biopharma $12.50 a share, an 85% premium over the company’s closing price on Monday of $6.68 a share.
During the last nine years, the cumulative amount of AI investments across the pharma and biotech sectors has increased by almost thirtyfold, to $24.6 billion as of last December.
Orthodontic Details says its customers might not realize the extent to which artificial intelligence is integrated into the company’s platform, but the technology is having a profound impact on their office operations.
Researcher Terry Loghmani and two colleagues have developed a medical device they say can help physical therapists monitor the level of pressure they apply to the soft tissue of patients seeking greater mobility and pain relief.
A group of about 30 independent medical practices in Indiana, called Indiana Physicians Health Alliance Inc., registered with the state in July as a not-for-profit after nearly two years of organizing.
With the new multimillion-dollar conference that kicks off on Tuesday, Indiana is trying to position itself as a globally known innovation hub. And health care will figure prominently on the agenda.
In this week’s edition of the podcast, Schmidt shares his story of recovery from a near fatal injury and how he uses it to help inspire others with mobility issues.
The pharmaceutical company has launched 20 drugs in the past decade to treat diseases from arthritis and psoriasis to diabetes and cancer. In recent months, Lilly has overtaken every competitor to become the most valuable drugmaker in the world.
The IU School of Medicine scored a major coup five years ago when it recruited one of the nation’s top experts in the fast-growing field of regenerative medicine. But the University of Pittsburgh recruited him away this spring.
Indiana-based Inotiv Inc. reported a fiscal third quarter profit of $1.8 million, compared with a loss of $3.7 million during the same period last year. However, the pharmaceutical testing company said it is facing new shareholder lawsuits primarily related to its acquisition of Envigo RMS Holding Corp. in Indianapolis.
The U.S. Food and Drug Administration gave the green light to MBX to test a drug for post-bariatric hypoglycemia, a rare disease and a serious complication of bariatric surgery, the company said Monday.
The new effort involves Purdue University, the Indiana University School of Medicine and medical device company Cook Medical. It was created to develop new technologies for the underserved pediatric population.
Indiana University Health’s 70,000-square-foot pharmacy hub and distribution center in Plainfield has enough pills, lotions, and infusible and injectable drugs under one roof to supply its 16 hospitals and hundreds of clinics for weeks.
The list includes a hospital executive who collects guitars but can’t play them, and a health insurance leader whose dream job is to become a professional sports coach.
It’s turnaround time at Riverview Health, the small, 114-year-old hospital system owned by Hamilton County, which is trying to deal with competition from larger health care systems.
West Lafayette-based Neurava is one of 61 companies from around the world to showcase its medical technology as part of the 11th annual MedTech Innovator, billed as the largest accelerator of med tech companies.
IU Health expects to give about $690 million worth of work to diversity contractors. That’s 30% of $2.3 billion—the amount the hospital system says the project is worth after subtracting the cost of expensive medical equipment such as imaging scanners.